Avita Medical Inc (RCEL)

R&D Expense Growth

2.35%

Fiscal year · Period ending:

RCEL logo

RCEL R&D Expense Growth

Latest reported2.35%
RCEL FY R&D Growth (YoY) (0.00% → 2.35%)
High-resolution chart · PNG

RCEL r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Avita Medical Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
2.3527%
-2.2141%
50.2562%
-11.5642%
5.743%
61.6979%
-19.951%
-13.6929%
110.7494%
82.3094%
-9.425%
76.4836%
-16.0947%
159.53%
350.359%
12.7517%
-5.9009%
29.9543%
-74.2666%
-65.7998%
17.3764%
155.4472%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.